These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1193 related articles for article (PubMed ID: 4712593)

  • 21. Lymphocyte-mediated immune responses in neoplasia.
    Pilch YH; Golub SH
    Am J Clin Pathol; 1974 Aug; 62(2):184-211. PubMed ID: 4602086
    [No Abstract]   [Full Text] [Related]  

  • 22. Hybrid cells derived from fusion of TA2-Ha ascites carcinoma with normal fibroblasts. II. Characterization of isoantigenic variant sublines.
    Friberg S; Klein G; Wiener F; Harris H
    J Natl Cancer Inst; 1973 May; 50(5):1269-86. PubMed ID: 4712591
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN; Florentz K; Güttler F
    Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro evidence of specific BCG-induced immunity to malignant melanoma in BALB-c mice.
    Faraci RP; Barone JJ; Marrone JC; Schour L
    J Natl Cancer Inst; 1974 Jun; 52(6):1913-5. PubMed ID: 4834418
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity.
    Silagi S; Newcomb EW; Weksler ME
    Cancer Res; 1974 Jan; 34(1):100-4. PubMed ID: 4358536
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 27. The genetics of cytostasis [proceedings].
    de Giorgi L; Biasi G; Festenstein H
    Folia Biol (Praha); 1976; 22(6):437-8. PubMed ID: 1001565
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 29. Demonstration and identification of cytotoxic antibodies and antibodies blocking the cell-mediated antitumor immunity against adenovirus type 12-induced tumors.
    Ankerst J
    Cancer Res; 1971 Jul; 31(7):997-1003. PubMed ID: 4327089
    [No Abstract]   [Full Text] [Related]  

  • 30. Tumor-specific cellular immunity.
    Cohen AM; Burdick JF; Ketcham AS
    J Surg Res; 1971 Aug; 11(8):421-31. PubMed ID: 4936302
    [No Abstract]   [Full Text] [Related]  

  • 31. Eradication of lymphoma cells with allogeneic immune peritoneal cells.
    Dullens HF; den Otter W
    Experientia; 1973 Apr; 29(4):479-81. PubMed ID: 4708353
    [No Abstract]   [Full Text] [Related]  

  • 32. Augmentation of antigen-specific cytotoxicity by concanavalin A at the peak of response to tumor allografts.
    Shimamoto Y; Nomoto K; Taniguchi K; Kubo C
    Cell Immunol; 1979 Sep; 47(1):204-10. PubMed ID: 92366
    [No Abstract]   [Full Text] [Related]  

  • 33. Non-reactivity of incompatible lymphoid cells from f1 modified radiation chimeras to host tumour cells in vitro.
    Grant CK; Ilbery PL
    Biomedicine; 1973 Feb; 19(2):56-60. PubMed ID: 4581503
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell-mediated immunity to virus-induced tumors: generation of lymphocytes sensitized to specific transplantation antigen in mouse cells infected with papovavirus SV40.
    Tevethia SS; Tevethia MJ
    Prog Med Virol; 1975; 21():103-17. PubMed ID: 174151
    [No Abstract]   [Full Text] [Related]  

  • 36. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.
    Röllinghoff M; Rouse BT; Warner NL
    J Natl Cancer Inst; 1973 Jan; 50(1):159-72. PubMed ID: 4571237
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens.
    Chism SE; Burton RC; Warner NL
    J Natl Cancer Inst; 1976 Aug; 57(2):377-87. PubMed ID: 63560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Destruction of experimental malignant melanoma by mediators of cellular immunity.
    Youdim S
    Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of tumor size and surgical resection on cell-mediated immunity in mice.
    Whitney RB; Levy JG; Smith AG
    J Natl Cancer Inst; 1974 Jul; 53(1):111-6. PubMed ID: 4835101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.